Search Results (1 to 10 of 5686 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 1681 Journal of Medical Internet Research
- 980 JMIR Research Protocols
- 661 JMIR Formative Research
- 470 JMIR mHealth and uHealth
- 237 JMIR Public Health and Surveillance
- 236 JMIR Mental Health
- 184 JMIR Medical Informatics
- 166 JMIR Human Factors
- 157 Online Journal of Public Health Informatics
- 95 JMIR Cancer
- 85 JMIR Serious Games
- 83 JMIR Aging
- 78 Iproceedings
- 75 JMIR Pediatrics and Parenting
- 64 JMIR Medical Education
- 63 Interactive Journal of Medical Research
- 61 JMIR Cardio
- 50 JMIR Diabetes
- 49 JMIR Rehabilitation and Assistive Technologies
- 36 JMIR Dermatology
- 34 JMIRx Med
- 28 Journal of Participatory Medicine
- 25 JMIR Perioperative Medicine
- 21 JMIR Nursing
- 20 JMIR AI
- 20 JMIR Infodemiology
- 9 JMIR Biomedical Engineering
- 8 JMIR Bioinformatics and Biotechnology
- 4 JMIR Neurotechnology
- 2 Asian/Pacific Island Nursing Journal
- 1 JMIR Data
- 1 JMIR XR and Spatial Computing
- 1 JMIR XR and Spatial Computing (JMXR)
- 1 Medicine 2.0
- 0 iProceedings
- 0 JMIR Preprints
- 0 JMIR Challenges
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
A power analysis estimating repeated measures within-between interaction, assuming a small effect size (f=0.15), determined that approximately 110 total participants are required to provide an 80% chance of detecting an effect between the 2 experimental conditions (tailored intervention vs active control) across 3 time points (0, 3, and 6 months postintervention). To account for an estimated 10%-15% attrition, at least 100 participants needed to be recruited.
JMIR Res Protoc 2025;14:e60790
Download Citation: END BibTex RIS
Infoveillance of COVID-19 Infections in Dentistry Using Platform X: Descriptive Study
J Med Internet Res 2025;27:e54650
Download Citation: END BibTex RIS
Administration–approved medications for dementia
Deprescribing anticholinergic medications: discontinuation or nonrenewal of any of the 41 medications in table 7 (“Drugs with strong anticholinergic properties”) of the American Geriatrics Society Beers Criteria [93]
Laboratory tests (cognitive indication only): thyroid-stimulating hormone, vitamin B12, glycated hemoglobin, complete blood count, basic metabolic panel, liver tests, HIV antigen and antibody combination, and syphilis immunoglobulin G and immunoglobulin M
JMIR Res Protoc 2025;14:e60471
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section